MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...icines for all patients with MDR-TB.
more
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Руководство представляет информацию о процедурах диагностики, порядке формирования схем лечения, осуществления клинического мониторинга эффективности и безопа...ности лечения на уровне пилотных районов, а также проведение программной оценки реализации краткосрочных схем и новых препаратов для лечения больных с М/ШЛУ-ТБ в условиях Таджикистана.
more
A survey of prevention, testing and treatment policies and practices
Patients and TB: Improving treatment outcomes through a patient centred approach and access to new treatments
5th TB Symposium – Eastern Europe and Central Asia Ministry of Labour, Health and Social Affairs of Georgia and Médecins Sans Frontières
22- 23 March , 2016 , TBILISI , GEORGIA
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...tandardised questionnaires and the Global TB Drug Facility website.
more
Protocol clinic naţional
PCN- 123
Framework for implementation.
The END TB Strategy.